Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead Acquires IP on Nanosensor Biomolecular Interaction Tech from University of Munich

NEW YORK, May 18 (GenomeWeb News) - Arrowhead Research has acquired intellectual property on nanosensor technology for measuring biomolecular interactions from the Universityof Munich, the company said today.

 

Arrowhead, based in Pasadena, Calif., said it paid a "de minimus," or insignificant, amount of cash for the patents and patent applications.

 

The technology, developed by Hermann Gaub, a professor of biophysics at the Center for Nanoscience at the Universityof Munich, relies on single-molecule force spectroscopy and is sensitive enough to detect single base air mismatches of DNA. The patent applications cover parallel assays for placing millions of sensors on a chip.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.